Literature DB >> 11230768

Comparison of trochlear block recession and trochlear wedge recession for canine patellar luxation using a cadaver model.

A L Johnson1, C W Probst, C E Decamp, D S Rosenstein, J G Hauptman, B T Weaver, T L Kern.   

Abstract

OBJECTIVE: To compare trochlear block recession (TBR) to trochlear wedge recession (TWR) with regards to patellar depth (percentage of patellar volume under the trochlear ridges), patellar articular contact, percentage of recessed trochlear surface area, and resistance to patellar luxation. STUDY
DESIGN: In vitro computed tomography (CT) and biomechanical evaluation using a cadaver model. SAMPLE POPULATION: Twelve normal, large-breed canine cadavers.
METHODS: Bilateral pelvic limb specimens with intact stifle joints were mounted on a positioning device. The femoral trochlear ridges were reduced to provide a standard shallow trochlea. TBR or TWR was performed to a standard depth randomly on paired specimens. CT and biomechanical evaluations were performed pre- and postoperatively in both an extended (148 degrees ) and flexed (113 degrees ) stifle position. CT images were digitized and measurements made using an image-analysis software program. Biomechanical testing consisted of applying 40 degrees of internal tibial rotation and documenting patellar luxation.
RESULTS: The change in trochlear depth (depth of recession) was not significantly different between groups. In the extended stifle position (patella in the proximal trochlea), patellar depth and patellar articular contact with the recessed trochlea were significantly greater after TBR compared with TWR. The percentage of recessed trochlear surface area was significantly greater after TBR compared with TWR. In the extended position, a smaller percentage of the patellae luxated within 40 degrees of internal tibial rotation after TBR compared with TWR.
CONCLUSIONS: TBR increases proximal patellar depth, increases patellar articular contact with the recessed proximal trochlea, recesses a larger percentage of trochlear surface area, and results in a greater resistance to patellar luxation in an extended position as compared with TWR. CLINICAL RELEVANCE: TBR may help limit the development of stifle DJD in dogs treated for canine patellar luxation. Copyright 2001 by The American College of Veterinary Surgeons.

Entities:  

Mesh:

Year:  2001        PMID: 11230768     DOI: 10.1053/jvet.2001.21391

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  7 in total

1.  Patellar luxation: pathogenesis and surgical correction.

Authors:  Greg Harasen
Journal:  Can Vet J       Date:  2006-10       Impact factor: 1.008

2.  Comparison of complication rates of unilateral, staged bilateral, and single-session bilateral surgery for the treatment of bilateral medial patellar luxation in dogs.

Authors:  Bronwyn A Fullagar; Päivi Rajala-Schultz; Bianca F Hettlich
Journal:  Can Vet J       Date:  2017-01       Impact factor: 1.008

Review 3.  Patellar luxation in dogs.

Authors:  Francesco Di Dona; Giovanni Della Valle; Gerardo Fatone
Journal:  Vet Med (Auckl)       Date:  2018-05-31

4.  Tibial tuberosity transposition advancement for treatment of concomitant cranial cruciate ligament rupture and medial patellar luxation in four feline stifles.

Authors:  Edyta Bula; Karen L Perry
Journal:  JFMS Open Rep       Date:  2021-09-18

5.  Failure of Passive Transfer in Camel Calves: 4 Cases (2010-2019).

Authors:  Amanda James; Joe Smith; Julie Sheldon; Ricardo Videla
Journal:  Case Rep Vet Med       Date:  2022-04-23

6.  The epidemiology of patellar luxation in dogs attending primary-care veterinary practices in England.

Authors:  Dan G O'Neill; Richard L Meeson; Adam Sheridan; David B Church; Dave C Brodbelt
Journal:  Canine Genet Epidemiol       Date:  2016-06-08

7.  Lesions in canine stifle joints due to trochleoplasties as treatment for medial patellar luxation.

Authors:  Johannes Hans van der Zee
Journal:  J S Afr Vet Assoc       Date:  2015-07-01       Impact factor: 1.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.